Amgen, Hospira Battle Over Experts Ahead Of Patent Trial
Pharmaceutical company Amgen Inc. sparred Wednesday in Delaware federal court with competitor Hospira Inc. over expert reports each side is hoping to use at a September patent infringment trial on Hospira's...To view the full article, register now.
Already a subscriber? Click here to view full article